| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |